跳至主要内容
临床试验/ACTRN12612000997853
ACTRN12612000997853已完成未知

A randomised controlled trial of a 12-month telephone-delivered weight loss intervention compared to usual care for overweight and obese women following treatment for breast cancer

The University of Queensland0 个研究点目标入组 160 人开始时间: 2012年9月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
Female

入选标准

  • Diagnosed with stage I-III breast cancer
  • Finished primary treatment for breast cancer (i.e., surgery, chemotherapy and/or radiotherapy)
  • Body Mass Index between 25 and 45 kg/m2

排除标准

  • Diagnosed with ductal carcinoma in situ (DCIS; stage 0) or distant metastases (stage IV)
  • Contraindications to participating in an unsupervised program – receiving dialysis, mobility issues, planning hip/knee replacement in next six months, taking Warfarin, pregnant, active heart disease, breathing problems, use of weight loss medications, weight loss surgery
  • Unable to travel to Brisbane to complete study assessments
  • Not sufficiently fluent in English to complete assessments and
  • participate in telephone-delivered program
  • Reporting depression/anxiety/other mental health condition as a current significant problem that would interfere with study participation

研究者

相似试验